These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


176 related items for PubMed ID: 6753107

  • 1. Release of gastric inhibitory polypeptide and insulin in response to intrajejunal glucose in duodenal ulcer patients before and after truncal vagotomy.
    Lauritsen KB, Moesgaard F, Nielsen ML, Jensen SL.
    Scand J Gastroenterol; 1982 Jun; 17(4):507-11. PubMed ID: 6753107
    [Abstract] [Full Text] [Related]

  • 2. Gastric inhibitory polypeptide (GIP) and insulin release in duodenal ulcer patients.
    Cataland S, O'Dorisio TM, Crockett SE, Mekhjian HS.
    J Clin Endocrinol Metab; 1978 Sep; 47(3):615-9. PubMed ID: 400727
    [Abstract] [Full Text] [Related]

  • 3. The response of gastric inhibitory polypeptide (GIP) and insulin to glucose in duodenal ulcer patients.
    Lauritsen KB, Moody AJ.
    Diabetologia; 1978 Mar; 14(3):149-53. PubMed ID: 658630
    [Abstract] [Full Text] [Related]

  • 4. Influence of vagotomy upon GIP release in patients with peptic ulcer.
    Imamura M, Kameyama J, Naito H, Sato T, Ohneda A.
    Tohoku J Exp Med; 1984 Jul; 143(3):335-44. PubMed ID: 6385345
    [Abstract] [Full Text] [Related]

  • 5. Serum gastric inhibitory polypeptide (GIP) in duodenal ulcer disease: relationship to glucose tolerance, insulin, and gastrin release.
    Arnold R, Creutzfeldt W, Ebert R, Becker HD, Börger HW, Schafmayer A.
    Scand J Gastroenterol; 1978 Jul; 13(1):41-7. PubMed ID: 635445
    [Abstract] [Full Text] [Related]

  • 6. The evidence for the regulatory role of endogenous GIP as a glucose dependent insulinotropic hormone in patients with duodenal ulcer.
    Takemura J, Seino Y, Yamamura T, Yoshiya K, Ishikawa Y, Itoh N, Imura H.
    Clin Endocrinol (Oxf); 1983 Sep; 19(3):345-53. PubMed ID: 6354520
    [Abstract] [Full Text] [Related]

  • 7. Effects of truncal, selective, and highly selective vagotomy on glucose tolerance and insulin secretion in patients with duodenal ulcer. Part I-Effect of vagotomy on response to oral glucose.
    Humphrey CS, Dykes JR, Johnston D.
    Br Med J; 1975 Apr 19; 2(5963):112-4. PubMed ID: 1125698
    [Abstract] [Full Text] [Related]

  • 8. [The effect of selective proximal vagotomy on gastrin, GIP and insulin blood levels in patients with duodenal ulcer].
    Börger HW, Schafmayer A, Becker HD.
    Chir Forum Exp Klin Forsch; 1978 Apr 19; (1978):25-9. PubMed ID: 752595
    [Abstract] [Full Text] [Related]

  • 9. Localization of gastric inhibitory polypeptide release by intestinal glucose perfusion in man.
    Thomas FB, Shook DF, O'Dorisio TM, Cataland S, Mekhjian HS, Caldwell JH, Mazzaferri EL.
    Gastroenterology; 1977 Jan 19; 72(1):49-54. PubMed ID: 830237
    [Abstract] [Full Text] [Related]

  • 10. [Influence of truncal vagotomy on serum- GIP and glucose homeostasis (author's transl)].
    Schafmayer A, Ebert R, Becker HD.
    Z Gastroenterol; 1979 Aug 19; 17(8):511-7. PubMed ID: 506354
    [Abstract] [Full Text] [Related]

  • 11. The correlation between gastric emptying time and the response of GIP and enteroglucagon to oral glucose in duodenal ulcer patients.
    Lauritsen KB, Frederiksen HJ, Uhrenholdt A, Holst JJ.
    Scand J Gastroenterol; 1982 Jun 19; 17(4):513-6. PubMed ID: 6753108
    [Abstract] [Full Text] [Related]

  • 12. Effects of truncal, selective, and highly selective vagotomy on glucose tolerance and insulin secretion in patients with duodenal ulcer. Part II-Comparison of response to oral and intravenous glucose.
    Humphrey CS, Dykes JR, Johnston D.
    Br Med J; 1975 Apr 19; 2(5963):114-6. PubMed ID: 1125699
    [Abstract] [Full Text] [Related]

  • 13. The response of plasma gastric-inhibitory polypeptide (GIP) to slow and fast glucose ingestion in Billroth II resected patients and normal controls.
    Jorde R, Schulz TB, Burhol PG, Schulz LB.
    Regul Pept; 1981 Nov 19; 2(6):391-9. PubMed ID: 7029674
    [Abstract] [Full Text] [Related]

  • 14. Gastric inhibitory polypeptide and insulin release in response to oral and intravenous glucose in coeliac disease.
    Lauritsen KB, Lauritzen JB, Christensen KC.
    Scand J Gastroenterol; 1982 Mar 19; 17(2):241-5. PubMed ID: 6753103
    [Abstract] [Full Text] [Related]

  • 15. Stimulation of gastric inhibitory polypeptide in normal and duodenal ulcer patients.
    Cataland S, O'Dorisio TM, Brooks R, Mekhjian HS.
    Gastroenterology; 1977 Jul 19; 73(1):19-22. PubMed ID: 863190
    [Abstract] [Full Text] [Related]

  • 16. Release of gastric inhibitory polypeptide (GIP) during calcium infusion and in hyperparathyroidism.
    Toyota T, Nakanome C, Akai H, Umezu M, Goto Y.
    Regul Pept; 1982 Jun 19; 4(1):1-12. PubMed ID: 6750703
    [Abstract] [Full Text] [Related]

  • 17. The effects of xylitol on the secretion of insulin and gastric inhibitory polypeptide in man and rats.
    Salminen S, Salminen E, Marks V.
    Diabetologia; 1982 Jun 19; 22(6):480-2. PubMed ID: 7049804
    [Abstract] [Full Text] [Related]

  • 18. Beta-adrenergic stimulation and blockade of the release of gastric inhibitory polypeptide and insulin in man.
    Flaten O, Sand T, Myren J.
    Scand J Gastroenterol; 1982 Mar 19; 17(2):283-8. PubMed ID: 6127792
    [Abstract] [Full Text] [Related]

  • 19. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.
    Andersen DK, Elahi D, Brown JC, Tobin JD, Andres R.
    J Clin Invest; 1978 Jul 19; 62(1):152-61. PubMed ID: 659629
    [Abstract] [Full Text] [Related]

  • 20. [The effect of calcium on the release of gastric inhibitory polypeptide (GIP) - with reference to the release of GIP in patients with hyperparathyroidism (author's transl)].
    Nakanome C, Akai H, Umezu M, Toyota T, Goto Y, Furukawa Y, Sato T, Yumita S, Bloom SR.
    Nihon Naibunpi Gakkai Zasshi; 1982 Feb 20; 58(2):98-109. PubMed ID: 7044844
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.